76.31

1.97% -1.53

After Hours: 76.45 0.14 +0.18%

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $76.31, with a volume of 866.79K. It is down -1.97% in the last 24 hours and up +17.65% over the past month. Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Previous Close:

$77.84

Open:

$77.08

24h Volume:

866.79K

Relative Volume:

0.94

Market Cap:

$5.06B

Revenue:

$1.50B

Net Income/Loss:

$427.61M

P/E Ratio:

12.70

EPS:

6.01

Net Cash Flow:

$423.98M

1W Performance:

+1.17%

1M Performance:

+17.65%

6M Performance:

+39.38%

1Y Performance:

-24.05%

1-Day Range:

$75.15

$77.19

1-Week Range:

$72.94

$80.00

52-Week Range:

$47.25

$111.29

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

808

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH Lantheus Holdings Inc	76.31	5.16B	1.50B	427.61M	423.98M	6.01
TAK Takeda Pharmaceutical Co Adr	17.76	57.56B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	122.23	53.17B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.33	46.62B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	31.75	38.33B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	485.06	21.48B	3.13B	1.27B	1.12B	26.39

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-25	Upgrade	Truist	Hold → Buy
Oct-08-25	Downgrade	Goldman	Buy → Neutral
Aug-12-25	Downgrade	Truist	Buy → Hold
Dec-18-24	Initiated	Goldman	Buy
Sep-03-24	Initiated	Redburn Atlantic	Buy
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

05:52 AM

Quantbot Technologies LP Makes New Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat

05:52 AM

Mar 04, 2026

Equity award, tax share disposition for Lantheus (LNTH) officer - Stock Titan

Mar 04, 2026

Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan

Mar 04, 2026

Lantheus Holdings (LNTH) CFO nets PSU award, withholds shares for taxes - Stock Titan

Mar 04, 2026

Mar 03, 2026

William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat

Mar 03, 2026

Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat

Mar 03, 2026

Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada

Mar 03, 2026

Mar 02, 2026

Lantheus receives FDA tentative approval for generic cancer drug - Investing.com India

Mar 02, 2026

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® - The Manila Times

Mar 02, 2026

FDA tentatively backs new tumor therapy similar to LUTATHERA - Stock Titan

Mar 02, 2026